Pay in 4 interest-free payments of $470.00 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
Voltaren Emulgel
LOX regulates EGFR cell surface retention to drive tumour progression
CAS Number: 75330-75-5
oxidative stress and pro-inflammatory cytokine production
Bone morphogenetic protein-focused strategies to induce cytotoxicity in lung cancer cells
Trabectedin - CAS# 114899-77-3 pone Voltaren EmulgelTrabectedin (also known as ecteinascidin 743 or ET 743, trade name Yondelis) is an antitumor chemotherapy drug sold by Pharma Mar S. A. and Johnson and Johnson under the brand name Yondelis. It is approved for use in Europe, Russia, and South Korea for the treatment of advanced soft tissue sarcoma. It is also undergoing clinical trials for the treatment of breast, prostate, and paediatric sarcomas. The European Commission and the U. S. Food and Drug
US$ 99.00
US$ 22.95
US$ 43.00
US$ 20.00
US$ 4999.50
US$ 4999.50
US$ 4999.50
US$ 4999.50